HDFC Life Insurance Company Regulatory Approval

Debt & Borrowing

HDFC Life Insurance Company Debt & Borrowing: ₹57.15 Cr

HDFC Life intimated the record date for annual 7.63% interest on 74,900 listed NCDs. Coupon of ~₹57.15 Crore is payable December 15, 2026.

Value

₹57.15 Cr

Annual General Meeting

HDFC Life Insurance Company Annual General Meeting

HDFC Life seeks shareholder approval for an IFSC insurance office at GIFT City, a foreign branch. E-voting runs till November 26, 2026.

Execution

E-voting from October 28, 2026 to November 26, 2026

Earnings Call

HDFC Life Insurance Company Investor Presentation: Key Takeaways

H1 FY27: VNB ₹2,037 cr (+12%), NBM 24.7%, PAT ₹1,119 cr (+13%), EV ₹66,461 cr, ROEV 14.9%, solvency 180%.

Other Announcement

HDFC Life Insurance Company Other Announcement

HDFC Life filed its security cover certificate under Regulation 54(3) for the quarter ended September 30, 2026, confirming its NCDs are unsecured.

Financial Results

HDFC Life Insurance Company Q2 FY27 Results: Net Profit ₹521.6 Cr, Up 16.4% YoY

HDFC Life Insurance Company Ltd reported revenue from operations of ₹409.8 Cr (+13.2% YoY) and net profit of ₹521.6 Cr (+16.4% YoY) for Q2 FY27.

Key figure

Net profit ₹521.6 Cr · +16.4% YoY

Debt & Borrowing

HDFC Life Insurance Company Debt & Borrowing: ₹80.5 Cr

HDFC Life Insurance Company Limited successfully paid Rs. 80.50 Crore in annual interest for its unsecured non-convertible debentures. The payment was completed on October 9, 2026.

Value

₹80.50 Cr

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.

Regulatory ApprovalBliss GVS Pharma Ltd BLISSGVSAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Bliss GVS Pharma Regulatory Approval

Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.

Regulatory ApprovalJohn Cockerill India Ltd COCKERILLAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

John Cockerill India Regulatory Approval

John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.